נאופרו 4 מ"ג / 24 שעות

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

ROTIGOTINE 4 MG / 24 HOUR

Mevcut itibaren:

CTS LTD

ATC kodu:

N04BC09

Farmasötik formu:

PATCHES

Uygulama yolu:

TRANSDERMAL

Tarafından üretildi:

UCB MANUFACTURING IRELAND LTD

Terapötik grubu:

ROTIGOTINE

Terapötik endikasyonlar:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Yetkilendirme tarihi:

2012-09-01